CYCLOCORT
LOE ApproachingNDATOPICALLOTION
Approved
Jun 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CYCLOCORT is a topical corticosteroid lotion approved in 1988 for inflammatory skin conditions. The drug is a small-molecule corticosteroid delivered via topical application. It works by reducing inflammation and suppressing immune response in affected skin areas.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure; commercial team likely focused on retention and generic transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CYCLOCORT positions offered through Astellas are primarily commercial in nature, supporting a mature product in its late lifecycle stage. Career growth on this product emphasizes sales excellence, account management, and transitional planning rather than innovation or market expansion.
Brand ManagerField Sales Representative
Worked on CYCLOCORT at Astellas? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.